Valens Semiconductor, Ltd. (NYSE:VLN) Short Interest Update

Valens Semiconductor, Ltd. (NYSE:VLN) was the target of a significant decrease in short interest in the month of February. As of February 13th, there was short interest totaling 386,274 shares, a decrease of 45.5% from the January 29th total of 708,980 shares. Approximately 0.9% of the company’s shares are sold short. Based on an average daily trading volume, of 826,206 shares, the short-interest ratio is presently 0.5 days. Based on an average daily trading volume, of 826,206 shares, the short-interest ratio is presently 0.5 days. Approximately 0.9% of the company’s shares are sold short.

Institutional Investors Weigh In On Valens Semiconductor

Institutional investors have recently bought and sold shares of the business. Squarepoint Ops LLC acquired a new stake in Valens Semiconductor in the 3rd quarter worth approximately $421,000. Susquehanna International Group LLP raised its position in shares of Valens Semiconductor by 120.7% in the third quarter. Susquehanna International Group LLP now owns 130,413 shares of the company’s stock valued at $233,000 after purchasing an additional 71,332 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of Valens Semiconductor by 417.3% in the second quarter. JPMorgan Chase & Co. now owns 86,081 shares of the company’s stock worth $226,000 after buying an additional 69,439 shares during the last quarter. &PARTNERS bought a new stake in shares of Valens Semiconductor during the 4th quarter worth $218,000. Finally, Creative Planning acquired a new position in Valens Semiconductor in the 2nd quarter valued at $213,000. 33.90% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

VLN has been the topic of several analyst reports. Wall Street Zen lowered shares of Valens Semiconductor from a “hold” rating to a “sell” rating in a report on Saturday. Needham & Company LLC decreased their price objective on shares of Valens Semiconductor from $4.00 to $3.00 and set a “buy” rating for the company in a research report on Thursday, November 13th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Valens Semiconductor in a research note on Monday, December 29th. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Valens Semiconductor currently has an average rating of “Hold” and an average target price of $3.00.

Valens Semiconductor Price Performance

Shares of NYSE VLN traded down $0.12 during midday trading on Friday, reaching $1.49. 1,159,763 shares of the company traded hands, compared to its average volume of 750,050. The stock has a 50-day moving average price of $1.67 and a 200 day moving average price of $1.75. Valens Semiconductor has a 52 week low of $1.37 and a 52 week high of $3.34.

Valens Semiconductor (NYSE:VLN) last issued its quarterly earnings results on Wednesday, February 25th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.01). Valens Semiconductor had a negative return on equity of 26.26% and a negative net margin of 44.72%.The business had revenue of $19.40 million during the quarter, compared to the consensus estimate of $18.78 million. Equities analysts expect that Valens Semiconductor will post -0.33 EPS for the current year.

About Valens Semiconductor

Valens Semiconductor Corp. is a provider of high-speed connectivity solutions, specializing in semiconductor chipsets that enable the transmission of uncompressed video, audio and data over common cabling such as twisted-pair and coax. The company’s flagship technology, HDBaseT, supports the simultaneous delivery of multiple signal types—including HDMI, USB, Ethernet and power—over a single cable. This multi-service approach addresses the growing demands of both consumer electronics and automotive infotainment systems, where bandwidth, reliability and low latency are critical.

Founded in 2012 and headquartered in Israel, Valens maintains research and development operations across North America, Europe and Asia.